Related Experiment Videos
Decision analysis in oncology: panacea or chimera?
1Department of Radiotherapy, St Bartholomew's Hospital, West Smithfield, London, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|September 1, 1992
Summary
Decision analysis in clinical oncology, despite its potential, remains underutilized due to challenges in probability assessment and outcome definition. Its primary value lies in developing clinical guidelines rather than individual patient decision-making.
Area of Science:
- Oncology
- Medical Decision Making
- Health Policy
Background:
- Decision analysis techniques have existed for over 25 years.
- Their application in clinical oncology remains limited, with only 19 studies identified.
Purpose of the Study:
- To review the literature on decision analysis in clinical oncology.
- To identify the advantages and disadvantages of its application.
- To assess its utility in clinical practice.
Main Methods:
- Literature review of decision analysis applications in clinical oncology.
- Analysis of identified studies to determine common themes, benefits, and drawbacks.
Main Results:
- Significant underutilization of decision analysis in clinical oncology.
- Key challenges include accurate probability assessment and defining outcome measures.
- Time-consuming analyses may yield equivocal results or confirm common sense.
- Incomplete designs limit the value of conclusions.
Conclusions:
- Decision analysis is valuable for identifying knowledge gaps and formulating management guidelines for treatment and follow-up.
- Its role in individual patient decision-making is limited.
- Wider adoption requires addressing challenges in data acquisition and methodology.